Northwest Biotherapeutics - Stock Price History | NWBO

Historical daily share price chart and data for Northwest Biotherapeutics since 2021 adjusted for splits. The latest closing stock price for Northwest Biotherapeutics as of December 16, 2016 is 0.57.
  • The all-time high Northwest Biotherapeutics stock closing price was 1307.35 on December 21, 2001.
  • The Northwest Biotherapeutics 52-week high stock price is 0.00, which is -100% above the current share price.
  • The Northwest Biotherapeutics 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average Northwest Biotherapeutics stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Northwest Biotherapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2016 1.0087 3.0600 3.0600 0.3220 0.5685 -82.23%
2015 7.4137 5.4200 12.2400 3.1200 3.2000 -40.19%
2014 5.8863 4.3500 9.1800 3.9400 5.3500 41.91%
2013 3.5930 3.2163 6.6600 3.1000 3.7700 20.85%
2012 5.0383 6.4000 10.9500 3.0300 3.1196 -46.14%
2011 8.6544 11.6800 14.1600 5.3600 5.7920 -53.59%
2010 14.0908 12.4800 25.6000 10.4000 12.4800 -1.27%
2009 12.3803 7.6800 24.0000 6.4000 12.6400 146.88%
2008 24.7570 40.9600 41.2800 3.0400 5.1200 -87.40%
2007 33.7313 16.7916 117.2800 11.9940 40.6400 142.03%
2006 58.1928 23.9880 148.7256 16.7916 16.7916 -30.00%
2005 38.3717 9.5952 79.2324 7.1964 23.9880 150.00%
2004 21.2466 55.1724 67.1664 4.7976 9.5952 -81.82%
2003 48.3761 38.3808 100.7496 14.3928 52.7736 37.50%
2002 571.5999 1211.3943 1256.9715 23.9880 38.3808 -96.80%
2001 1231.0208 1273.7631 1307.3463 1199.4003 1199.4003 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.995B $0.001B
Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86